Targeting ANXA3 in combination with sorafenib for the treatment of hepatocellular carcinoma

被引：0
|
作者：
Tong, Man
Luk, Steve
Che, Noelia
Ding, Jin
Lee, Terence K. W.
Ma, Stephanie
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3146
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of treatment efficacy between sorafenib monotherapy and sorafenib-based combination therapy in advanced hepatocellular carcinoma
    Lee, Sangheun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Ja Kyung
    Lee, Kwan Sik
    Han, Kwang-Hyub
    Chon, Chae Yoon
    HEPATOLOGY, 2012, 56 : 487A - 487A
  • [32] Mechanism of Action of Tumor Treating Fields (TTFields) in Combination with Sorafenib for Treatment of Hepatocellular Carcinoma
    Davidi, S.
    Shteingauz, A.
    Jacobovitch, S.
    Gotlib, K.
    Brami, C. Tempel
    Munster, M.
    Zeevi, E.
    Dor-On, E.
    Schneiderman, R. S.
    Voloshin, T.
    Haber, A.
    Giladi, M.
    Kinzel, A.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E47 - E48
  • [33] DOSE ESCALATION OF THE HDAC INHIBITOR RESMINOSTAT IN COMBINATION TREATMENT WITH SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Ganten, Tom
    Woerns, Marcus-Alexander
    Siveke, Jens
    Dollinger, Matthias
    Scheulen, Max
    Wege, Henning
    Mais, Anna
    Hauns, Bernhard
    Henning, Stefan
    Hentsch, Bernd
    Horger, Marius
    Lauer, Ulrich
    Bitzer, Michael
    ANNALS OF ONCOLOGY, 2012, 23 : 55 - 55
  • [34] Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation
    Gong, Quanyou
    Qin, Zhaoxia
    Hou, Fangli
    ONCOLOGY LETTERS, 2017, 14 (06) : 7045 - 7048
  • [35] Early experience of combination treatment of sorafenib and radiotherapy in patients with advanced hepatocellular carcinoma (HCC)
    Seong, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway
    Ling, Sunbin
    Song, Lei
    Fan, Ning
    Feng, Tingting
    Liu, Lu
    Yang, Xu
    Wang, Mingjie
    Li, Yanling
    Tian, Yu
    Zhao, Feng
    Liu, Ying
    Huang, Qihong
    Hou, Zhaoyuan
    Xu, Fei
    Shi, Lei
    Li, Yan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (01) : 297 - 309
  • [37] Adverse events of sorafenib in hepatocellular carcinoma treatment
    Pang, Yongsheng
    Eresen, Aydin
    Zhang, Zigeng
    Hou, Qiaoming
    Wang, Yining
    Yaghmai, Vahid
    Zhang, Zhuoli
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (06): : 2770 - 2782
  • [38] Guidelines for treatment of hepatocellular or renal carcinoma with sorafenib
    Rosmorduc, O.
    Chevreau, C.
    Dielenseger, P.
    Ederhy, S.
    Goldwasser, F.
    Grange, J. -D.
    Mortier, L.
    Neidhardt-Berard, M. -E.
    Robert, C.
    Scotte, F.
    Seitz, J. -F.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (03): : 161 - 167
  • [39] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
    Meyer, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04): : 218 - 220
  • [40] Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
    Xie, Bingru
    Wang, David H.
    Spechler, Stuart Jon
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (05) : 1122 - 1129
12345